Core Viewpoint - The company Gu Yu has made a significant breakthrough in the field of anti-aging skincare with the launch of its proprietary artificial exosome technology, "Human-like Exosome HME," which is set to revolutionize the industry by providing a safer and more effective anti-aging solution [1][4]. Group 1: Technology and Innovation - "Human-like Exosome HME" is synthesized through a high-precision engineering technique that mimics the natural structure of human-derived exosomes, creating a nano-sized vesicle system [3]. - The technology offers several advantages: 1. Safety: The artificial design avoids potential unknown risk factors associated with human-derived exosomes [3]. 2. Efficiency: It can load gene-level core components like miRNA and siRNA, enhancing cellular communication and significantly outperforming ordinary human-derived exosomes in promoting cell regeneration and collagen synthesis [3]. 3. Compliance: All components are listed in the national cosmetic ingredient directory or have passed new ingredient registration, with core technology receiving national invention patent authorization [3]. 4. Frontier: It represents a shift from "extracting nature" to "simulating life," marking a cutting-edge exploration in the field of exosome applications [3]. Group 2: Efficacy and Research - Experimental data supports the efficacy of "Human-like Exosome HME," showing its ability to promote cell migration is 1.17-1.5 times greater than that of ordinary human-derived exosomes, and its capacity to stimulate type III collagen production is 5-6.7 times higher [3]. - In human efficacy tests, the average reduction in wrinkle count after 14 days of use was 17.43%, with a further reduction of 26.61% after 28 days [4]. Group 3: Research and Development Commitment - Gu Yu has invested over 250 million yuan in research and development, establishing a comprehensive closed-loop system covering raw material research, formula development, and efficacy evaluation [4]. - The company has formed a deep collaboration with Xiamen University to establish a "Biomedicine Joint Research Center," expanding its research scope from skincare to broader health fields [5]. - Gu Yu has committed to investing 2 billion yuan in research over the next decade, demonstrating its long-term dedication to driving brand development through technological innovation [5].
外泌体抗老迎来中国方案:谷雨以“类人源外泌素HME”实现从技术跟跑到创新领跑
Cai Fu Zai Xian·2025-11-13 02:36